Am J Transplant, Volume 18, Suppl 3 Archives - Page 148 of 211 - ATC Abstracts

2018 American Transplant Congress
Genes with Housekeeping Function (GHF) in Renal Allograft Tissue: An RNA-Seq Analysis
Z. Wang,¹ L. Pan,² Z. Lyu,² G. Zeng,¹ P. Randhawa.¹
¹Department of Pathology, The Thomas E Starzl Transplantation Institute, University of Pittsburgh, School of Medicine, Pittsburgh, PA; ²Department of Nephrology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China; ³Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA.
RNA-sequencing (RNA-seq) is poised to play a major role in the management of kidney transplant patients. It is very desirable to develop a set of…
2018 American Transplant Congress
Long-Term Prognosis of BK Virus Associated Nephropathy in Kidney Transplant Recipients
W. Park,^1,3 S. Yeo,¹ S. Kang,^1,3 H. Park,¹ K. Jin,^1,3 S. Park,^1,3 M. Choe,^2,3 S. Han.^1,3
¹Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea; ²Pathology, Keimyung University School of Medicine, Daegu, Republic of Korea; ³Keimyung University Kidney Institute, Daegu, Republic of Korea.
Background: BK virus-associated nephropathy (BKVAN) is an important risk factor that results in an allograft loss in kidney transplant recipients (KTRs). The short-term prognosis of…
2018 American Transplant Congress
The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial
J. Yang, X. He, L. Wu, Z. Guo.
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Background: Hyperbilirubinemia is a common but reversible event after liver transplantation . Steroids is a widely used anti-inflammatory agent, which may help improve allograft function,…
2018 American Transplant Congress
Excellent Outcomes for HCV-Viremic Recipients of Simultaneous Liver-Kidney Transplant in the Direct Anti-Viral Era
A. Ray, C. Klein, T. Ommert, R. Cross, R. Rubin.
Piedmont Transplant Institute, Piedmont Healthcare, Atlanta, GA.
Before the era of direct anti-viral agents (DAAs), outcomes for HCV-viremic recipients of simultaneous liver kidney transplant (SLKT) were inferior to HCV-negative recipients. PURPOSE: To…
2018 American Transplant Congress
Portal Vein Flow as an Indicator of Liver Transplantation for Acute Liver Failure
C-.H. Cheng,¹ C. Lee,² Y-.C. Wang,¹ T-.H. Wu,¹ C-.F. Lee,¹ T-.J. Wu,¹ H. Chou,¹ K-.M. Chan,¹ W-.C. Lee.¹
¹Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan; ²Department of Hepatology, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.
Background: Liver transplantation is the most effective treatment for acute liver failure. Timing of liver transplantation is important to rescue the dying patients. This study…
2018 American Transplant Congress
Gastroparesis after Lung Transplantation: A Single-Center Experience
S. Biswas Roy,¹ M. Davis,² F. Rodriguez,³ R. Serrone,⁴ P. Kang,⁵ T. Ipsen,⁶ M. Smith,⁷ R. Bremner,⁷ J. Huang,⁷ J. Huang.⁷
¹St. Joseph's Hospital and Medical Center, Phoenix, AZ; ²University of Arizona College of Medicine, Phoenix, AZ; ³Grand Canyon University, Phoenix, AZ; ⁴St. Joseph's Hospital and Medical Center, Phoenix, AZ; ⁵University of Arizona College of Public Health, Phoenix, AZ; ⁶Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ; ⁷Norton Thoracic Institue, St. Joseph's Hospital and Medical Center, Phoenix, AZ.
Objective: Gastroparesis (GP), common in patients undergoing lung transplantation (LTx) for end-stage lung disease, can affect quality of life and absorbency of immunosuppressants. In this…
2018 American Transplant Congress
Identifying Specificity Groups in the CMV IE-1 T Cell Receptor Repertoire
M. Lucia,¹ F. Rubelt,² S. Luque,³ S. Krams,¹ C. Esquivel,¹ O. Bestard,³ O. Martinez.¹
¹Department of Surgery, Stanford University, Palo Alto; ²Institute for Immunity, Transplantation and Infection, Stanford University, Palo Alto; ³Experimental Nephrology, IDIBELL, Barcelona, Catalonia, Spain.
Cytomegalovirus (CMV) continues to be a major problem for organ transplant recipients. T cells specific to the CMV antigens immediate-early (IE-1) and pp65 CMV govern…
2018 American Transplant Congress
Transplant Psychiatry- A Growing Subspecialty. Introducing the Transplant Psychiatry Special Interest Group from the Academy of Psychosomatic Medicine
P. Zimbrean,¹ A. DiMartini,² C. Crone.³
¹Psychiatry and Surgery (Transplant), Yale University, New HAven, CT; ²Psychiatry and Transplant, University of Pittsburgh, Pittsburgh, PA; ³Psychiatry, Inova Hospital, Falls Church, VA.
Purpose: 1. To inform the AST community about the activities of Transplant Psychiatry Special Interest Group that has been operating within the Academy of Psychosomatic…
2018 American Transplant Congress
Donor-Derived Hepatitis B Virus (HBV) Infection: Analysis of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee (DTAC)
N. Theodoropoulos, S. Tlusty, G. Vece, G. Berry, J. Bucio, L. Danziger-Isakov, D. Florescu, D. Goldberg, C. Ho, R. La Hoz, K. Lilly, M. Malinis, A. Mehta, M. Nalesnik, R. Sawyer, L. Strasfeld, R. Wood, M. Michaels, C. Wolfe.
DTAC, United Network for Organ Sharing, Richmond, VA.
Introduction: HBV can be transmitted from organ donor to recipient and is one of the viruses targeted by US Public Health Service increased risk (IR)…
2018 American Transplant Congress
Identifying Differences in Antimicrobial Resistance with a Liver Transplant Antibiogram
J. Rago, M. Crotty, E. Milas, E. Dominguez.
Methodist Dallas Medical Center, Dallas.
Regulatory requirements for antimicrobial stewardship pose a unique challenge in special populations including transplant recipients. Infection following liver transplant can adversely impact patient outcomes. Moreover,…